-

$undefined

N/A

(N/A)

Matinas Biopharma NYSE MKT LLC:MTNB Matinas BioPharma is a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to advance standards of care for patients in areas of significant unmet medical need. Company leadership has a deep history and knowledge of drug development and is supported by a world-class team of scientific advisors.

Location: Suite 302, 1545 Route 206 South, New Jersey, 07921, US | Website: www.matinasbiopharma.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-4.468M

Cash

10.8M

Avg Qtr Burn

-4.239M

Short % of Float

6.23%

Insider Ownership

6.10%

Institutional Own.

6.87%

Qtr Updated

09/30/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
MAT2203 (Oral Amphotericin B) Details Meningitis, Cryptococcal meningitis, Azole-resistant infections, C. krusei infection, Fungal infections, Invasive Aspergillosis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LYPDISO (MAT9001) (Omega-3 Drug) Details Cardiovascular disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.